
BIIB News
Biogen Inc.
$250.79
-$0.86(-0.34%)
64
Overall
80
Value
66
Tech
47
Quality
Market Cap
$37.07B
Volume
968.96K
52W Range
$160.37 - $261.00
Target Price
$268.63
BIIB news: the latest Biogen Inc. headlines, press releases and market updates, newest first.
Latest BIIB News
- Analysts Conflicted on These Healthcare Names: Biogen (BIIB), Filana Therapeutics (FLNA) and Erasca (ERAS)TipRanks Newsroom · Nov 13, 2026
- Biogen’s Tysabri Study Update: What BIIB Investors Should WatchTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 12, 2026
- Wells Fargo Remains a Buy on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- Biogen (BIIB) Receives a Buy from TD CowenTipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Elevance Health (ELV) and Myriad Genetics (MYGN)TipRanks Newsroom · Oct 22, 2026
- Wells Fargo Reaffirms Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Wells Fargo Reaffirms Their Buy Rating on Biogen (BIIB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Biogen’s BIIB147 ALS Trial: A Long-Horizon Catalyst for Neurology InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 19, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $250.79 | -0.3% | 968.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |